 | • レポートコード：MRC308GR09506 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のHP1抗体の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のHP1抗体市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– HP1抗体の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
HP1抗体市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・モノクローナル、ポリクローナル
用途別セグメント
・ウェスタンブロット（WB）、免疫化学（IHC）、免疫蛍光（IF）、ELISA、その他
主要な市場プレーヤー
・GeneTex、Bioss、BosterBio、BMA Biomedicals、Abcam、RayBiotech、Thermo Fisher Scientific、Biorbyt、LifeSpan BioSciences、HUABIO、Santa Cruz Biotechnology、BPS Bioscience、EpiGentek、NSJ Bioreagents、Novus Biologicals、Affinity Biosciences、Cell Signaling Technology、ABclonal Technology、Leading Biology、BioVendor Laboratory Medicine、Active Motif、Abeomics、Jingjie PTM BioLab
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、HP1抗体製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なHP1抗体メーカーの企業概要、2019年～2022年までのHP1抗体の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なHP1抗体メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別HP1抗体の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのHP1抗体の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのHP1抗体市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびHP1抗体の産業チェーンを掲載しています。
・第14、15章では、HP1抗体の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– HP1抗体の概要
– 種類別分析（2018年vs2022年vs2029年）：モノクローナル、ポリクローナル
– 用途別分析（2018年vs2022年vs2029年）：ウェスタンブロット（WB）、免疫化学（IHC）、免疫蛍光（IF）、ELISA、その他
– 世界のHP1抗体市場規模・予測
– 世界のHP1抗体生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– GeneTex、Bioss、BosterBio、BMA Biomedicals、Abcam、RayBiotech、Thermo Fisher Scientific、Biorbyt、LifeSpan BioSciences、HUABIO、Santa Cruz Biotechnology、BPS Bioscience、EpiGentek、NSJ Bioreagents、Novus Biologicals、Affinity Biosciences、Cell Signaling Technology、ABclonal Technology、Leading Biology、BioVendor Laboratory Medicine、Active Motif、Abeomics、Jingjie PTM BioLab
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：モノクローナル、ポリクローナル
・用途別分析2018年-2029年：ウェスタンブロット（WB）、免疫化学（IHC）、免疫蛍光（IF）、ELISA、その他
・HP1抗体の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・HP1抗体のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・HP1抗体のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・HP1抗体の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・HP1抗体の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of HP1 Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global HP1 Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Monoclonal
1.3.3 Polyclonal
1.4 Market Analysis by Application
1.4.1 Overview: Global HP1 Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Western Blot (WB)
1.4.3 Immunochemistry (IHC)
1.4.4 Immunofluorescence (IF)
1.4.5 ELISA
1.4.6 Others
1.5 Global HP1 Antibody Market Size & Forecast
1.5.1 Global HP1 Antibody Consumption Value (2018 & 2022 & 2029)
1.5.2 Global HP1 Antibody Sales Quantity (2018-2029)
1.5.3 Global HP1 Antibody Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GeneTex
2.1.1 GeneTex Details
2.1.2 GeneTex Major Business
2.1.3 GeneTex HP1 Antibody Product and Services
2.1.4 GeneTex HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GeneTex Recent Developments/Updates
2.2 Bioss
2.2.1 Bioss Details
2.2.2 Bioss Major Business
2.2.3 Bioss HP1 Antibody Product and Services
2.2.4 Bioss HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Bioss Recent Developments/Updates
2.3 BosterBio
2.3.1 BosterBio Details
2.3.2 BosterBio Major Business
2.3.3 BosterBio HP1 Antibody Product and Services
2.3.4 BosterBio HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BosterBio Recent Developments/Updates
2.4 BMA Biomedicals
2.4.1 BMA Biomedicals Details
2.4.2 BMA Biomedicals Major Business
2.4.3 BMA Biomedicals HP1 Antibody Product and Services
2.4.4 BMA Biomedicals HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BMA Biomedicals Recent Developments/Updates
2.5 Abcam
2.5.1 Abcam Details
2.5.2 Abcam Major Business
2.5.3 Abcam HP1 Antibody Product and Services
2.5.4 Abcam HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Abcam Recent Developments/Updates
2.6 RayBiotech
2.6.1 RayBiotech Details
2.6.2 RayBiotech Major Business
2.6.3 RayBiotech HP1 Antibody Product and Services
2.6.4 RayBiotech HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 RayBiotech Recent Developments/Updates
2.7 Thermo Fisher Scientific
2.7.1 Thermo Fisher Scientific Details
2.7.2 Thermo Fisher Scientific Major Business
2.7.3 Thermo Fisher Scientific HP1 Antibody Product and Services
2.7.4 Thermo Fisher Scientific HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Thermo Fisher Scientific Recent Developments/Updates
2.8 Biorbyt
2.8.1 Biorbyt Details
2.8.2 Biorbyt Major Business
2.8.3 Biorbyt HP1 Antibody Product and Services
2.8.4 Biorbyt HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Biorbyt Recent Developments/Updates
2.9 LifeSpan BioSciences
2.9.1 LifeSpan BioSciences Details
2.9.2 LifeSpan BioSciences Major Business
2.9.3 LifeSpan BioSciences HP1 Antibody Product and Services
2.9.4 LifeSpan BioSciences HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 LifeSpan BioSciences Recent Developments/Updates
2.10 HUABIO
2.10.1 HUABIO Details
2.10.2 HUABIO Major Business
2.10.3 HUABIO HP1 Antibody Product and Services
2.10.4 HUABIO HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 HUABIO Recent Developments/Updates
2.11 Santa Cruz Biotechnology
2.11.1 Santa Cruz Biotechnology Details
2.11.2 Santa Cruz Biotechnology Major Business
2.11.3 Santa Cruz Biotechnology HP1 Antibody Product and Services
2.11.4 Santa Cruz Biotechnology HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Santa Cruz Biotechnology Recent Developments/Updates
2.12 BPS Bioscience
2.12.1 BPS Bioscience Details
2.12.2 BPS Bioscience Major Business
2.12.3 BPS Bioscience HP1 Antibody Product and Services
2.12.4 BPS Bioscience HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 BPS Bioscience Recent Developments/Updates
2.13 EpiGentek
2.13.1 EpiGentek Details
2.13.2 EpiGentek Major Business
2.13.3 EpiGentek HP1 Antibody Product and Services
2.13.4 EpiGentek HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 EpiGentek Recent Developments/Updates
2.14 NSJ Bioreagents
2.14.1 NSJ Bioreagents Details
2.14.2 NSJ Bioreagents Major Business
2.14.3 NSJ Bioreagents HP1 Antibody Product and Services
2.14.4 NSJ Bioreagents HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 NSJ Bioreagents Recent Developments/Updates
2.15 Novus Biologicals
2.15.1 Novus Biologicals Details
2.15.2 Novus Biologicals Major Business
2.15.3 Novus Biologicals HP1 Antibody Product and Services
2.15.4 Novus Biologicals HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Novus Biologicals Recent Developments/Updates
2.16 Affinity Biosciences
2.16.1 Affinity Biosciences Details
2.16.2 Affinity Biosciences Major Business
2.16.3 Affinity Biosciences HP1 Antibody Product and Services
2.16.4 Affinity Biosciences HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Affinity Biosciences Recent Developments/Updates
2.17 Cell Signaling Technology
2.17.1 Cell Signaling Technology Details
2.17.2 Cell Signaling Technology Major Business
2.17.3 Cell Signaling Technology HP1 Antibody Product and Services
2.17.4 Cell Signaling Technology HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Cell Signaling Technology Recent Developments/Updates
2.18 ABclonal Technology
2.18.1 ABclonal Technology Details
2.18.2 ABclonal Technology Major Business
2.18.3 ABclonal Technology HP1 Antibody Product and Services
2.18.4 ABclonal Technology HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 ABclonal Technology Recent Developments/Updates
2.19 Leading Biology
2.19.1 Leading Biology Details
2.19.2 Leading Biology Major Business
2.19.3 Leading Biology HP1 Antibody Product and Services
2.19.4 Leading Biology HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Leading Biology Recent Developments/Updates
2.20 BioVendor Laboratory Medicine
2.20.1 BioVendor Laboratory Medicine Details
2.20.2 BioVendor Laboratory Medicine Major Business
2.20.3 BioVendor Laboratory Medicine HP1 Antibody Product and Services
2.20.4 BioVendor Laboratory Medicine HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 BioVendor Laboratory Medicine Recent Developments/Updates
2.21 Active Motif
2.21.1 Active Motif Details
2.21.2 Active Motif Major Business
2.21.3 Active Motif HP1 Antibody Product and Services
2.21.4 Active Motif HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Active Motif Recent Developments/Updates
2.22 Abeomics
2.22.1 Abeomics Details
2.22.2 Abeomics Major Business
2.22.3 Abeomics HP1 Antibody Product and Services
2.22.4 Abeomics HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Abeomics Recent Developments/Updates
2.23 Jingjie PTM BioLab
2.23.1 Jingjie PTM BioLab Details
2.23.2 Jingjie PTM BioLab Major Business
2.23.3 Jingjie PTM BioLab HP1 Antibody Product and Services
2.23.4 Jingjie PTM BioLab HP1 Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Jingjie PTM BioLab Recent Developments/Updates
3 Competitive Environment: HP1 Antibody by Manufacturer
3.1 Global HP1 Antibody Sales Quantity by Manufacturer (2018-2023)
3.2 Global HP1 Antibody Revenue by Manufacturer (2018-2023)
3.3 Global HP1 Antibody Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of HP1 Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 HP1 Antibody Manufacturer Market Share in 2022
3.4.2 Top 6 HP1 Antibody Manufacturer Market Share in 2022
3.5 HP1 Antibody Market: Overall Company Footprint Analysis
3.5.1 HP1 Antibody Market: Region Footprint
3.5.2 HP1 Antibody Market: Company Product Type Footprint
3.5.3 HP1 Antibody Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global HP1 Antibody Market Size by Region
4.1.1 Global HP1 Antibody Sales Quantity by Region (2018-2029)
4.1.2 Global HP1 Antibody Consumption Value by Region (2018-2029)
4.1.3 Global HP1 Antibody Average Price by Region (2018-2029)
4.2 North America HP1 Antibody Consumption Value (2018-2029)
4.3 Europe HP1 Antibody Consumption Value (2018-2029)
4.4 Asia-Pacific HP1 Antibody Consumption Value (2018-2029)
4.5 South America HP1 Antibody Consumption Value (2018-2029)
4.6 Middle East and Africa HP1 Antibody Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global HP1 Antibody Sales Quantity by Type (2018-2029)
5.2 Global HP1 Antibody Consumption Value by Type (2018-2029)
5.3 Global HP1 Antibody Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global HP1 Antibody Sales Quantity by Application (2018-2029)
6.2 Global HP1 Antibody Consumption Value by Application (2018-2029)
6.3 Global HP1 Antibody Average Price by Application (2018-2029)
7 North America
7.1 North America HP1 Antibody Sales Quantity by Type (2018-2029)
7.2 North America HP1 Antibody Sales Quantity by Application (2018-2029)
7.3 North America HP1 Antibody Market Size by Country
7.3.1 North America HP1 Antibody Sales Quantity by Country (2018-2029)
7.3.2 North America HP1 Antibody Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe HP1 Antibody Sales Quantity by Type (2018-2029)
8.2 Europe HP1 Antibody Sales Quantity by Application (2018-2029)
8.3 Europe HP1 Antibody Market Size by Country
8.3.1 Europe HP1 Antibody Sales Quantity by Country (2018-2029)
8.3.2 Europe HP1 Antibody Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific HP1 Antibody Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific HP1 Antibody Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific HP1 Antibody Market Size by Region
9.3.1 Asia-Pacific HP1 Antibody Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific HP1 Antibody Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America HP1 Antibody Sales Quantity by Type (2018-2029)
10.2 South America HP1 Antibody Sales Quantity by Application (2018-2029)
10.3 South America HP1 Antibody Market Size by Country
10.3.1 South America HP1 Antibody Sales Quantity by Country (2018-2029)
10.3.2 South America HP1 Antibody Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa HP1 Antibody Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa HP1 Antibody Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa HP1 Antibody Market Size by Country
11.3.1 Middle East & Africa HP1 Antibody Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa HP1 Antibody Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 HP1 Antibody Market Drivers
12.2 HP1 Antibody Market Restraints
12.3 HP1 Antibody Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of HP1 Antibody and Key Manufacturers
13.2 Manufacturing Costs Percentage of HP1 Antibody
13.3 HP1 Antibody Production Process
13.4 HP1 Antibody Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 HP1 Antibody Typical Distributors
14.3 HP1 Antibody Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global HP1 Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global HP1 Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GeneTex Basic Information, Manufacturing Base and Competitors
Table 4. GeneTex Major Business
Table 5. GeneTex HP1 Antibody Product and Services
Table 6. GeneTex HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GeneTex Recent Developments/Updates
Table 8. Bioss Basic Information, Manufacturing Base and Competitors
Table 9. Bioss Major Business
Table 10. Bioss HP1 Antibody Product and Services
Table 11. Bioss HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Bioss Recent Developments/Updates
Table 13. BosterBio Basic Information, Manufacturing Base and Competitors
Table 14. BosterBio Major Business
Table 15. BosterBio HP1 Antibody Product and Services
Table 16. BosterBio HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BosterBio Recent Developments/Updates
Table 18. BMA Biomedicals Basic Information, Manufacturing Base and Competitors
Table 19. BMA Biomedicals Major Business
Table 20. BMA Biomedicals HP1 Antibody Product and Services
Table 21. BMA Biomedicals HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. BMA Biomedicals Recent Developments/Updates
Table 23. Abcam Basic Information, Manufacturing Base and Competitors
Table 24. Abcam Major Business
Table 25. Abcam HP1 Antibody Product and Services
Table 26. Abcam HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Abcam Recent Developments/Updates
Table 28. RayBiotech Basic Information, Manufacturing Base and Competitors
Table 29. RayBiotech Major Business
Table 30. RayBiotech HP1 Antibody Product and Services
Table 31. RayBiotech HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. RayBiotech Recent Developments/Updates
Table 33. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 34. Thermo Fisher Scientific Major Business
Table 35. Thermo Fisher Scientific HP1 Antibody Product and Services
Table 36. Thermo Fisher Scientific HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Thermo Fisher Scientific Recent Developments/Updates
Table 38. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 39. Biorbyt Major Business
Table 40. Biorbyt HP1 Antibody Product and Services
Table 41. Biorbyt HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Biorbyt Recent Developments/Updates
Table 43. LifeSpan BioSciences Basic Information, Manufacturing Base and Competitors
Table 44. LifeSpan BioSciences Major Business
Table 45. LifeSpan BioSciences HP1 Antibody Product and Services
Table 46. LifeSpan BioSciences HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. LifeSpan BioSciences Recent Developments/Updates
Table 48. HUABIO Basic Information, Manufacturing Base and Competitors
Table 49. HUABIO Major Business
Table 50. HUABIO HP1 Antibody Product and Services
Table 51. HUABIO HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. HUABIO Recent Developments/Updates
Table 53. Santa Cruz Biotechnology Basic Information, Manufacturing Base and Competitors
Table 54. Santa Cruz Biotechnology Major Business
Table 55. Santa Cruz Biotechnology HP1 Antibody Product and Services
Table 56. Santa Cruz Biotechnology HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Santa Cruz Biotechnology Recent Developments/Updates
Table 58. BPS Bioscience Basic Information, Manufacturing Base and Competitors
Table 59. BPS Bioscience Major Business
Table 60. BPS Bioscience HP1 Antibody Product and Services
Table 61. BPS Bioscience HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. BPS Bioscience Recent Developments/Updates
Table 63. EpiGentek Basic Information, Manufacturing Base and Competitors
Table 64. EpiGentek Major Business
Table 65. EpiGentek HP1 Antibody Product and Services
Table 66. EpiGentek HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. EpiGentek Recent Developments/Updates
Table 68. NSJ Bioreagents Basic Information, Manufacturing Base and Competitors
Table 69. NSJ Bioreagents Major Business
Table 70. NSJ Bioreagents HP1 Antibody Product and Services
Table 71. NSJ Bioreagents HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. NSJ Bioreagents Recent Developments/Updates
Table 73. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 74. Novus Biologicals Major Business
Table 75. Novus Biologicals HP1 Antibody Product and Services
Table 76. Novus Biologicals HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novus Biologicals Recent Developments/Updates
Table 78. Affinity Biosciences Basic Information, Manufacturing Base and Competitors
Table 79. Affinity Biosciences Major Business
Table 80. Affinity Biosciences HP1 Antibody Product and Services
Table 81. Affinity Biosciences HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Affinity Biosciences Recent Developments/Updates
Table 83. Cell Signaling Technology Basic Information, Manufacturing Base and Competitors
Table 84. Cell Signaling Technology Major Business
Table 85. Cell Signaling Technology HP1 Antibody Product and Services
Table 86. Cell Signaling Technology HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Cell Signaling Technology Recent Developments/Updates
Table 88. ABclonal Technology Basic Information, Manufacturing Base and Competitors
Table 89. ABclonal Technology Major Business
Table 90. ABclonal Technology HP1 Antibody Product and Services
Table 91. ABclonal Technology HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. ABclonal Technology Recent Developments/Updates
Table 93. Leading Biology Basic Information, Manufacturing Base and Competitors
Table 94. Leading Biology Major Business
Table 95. Leading Biology HP1 Antibody Product and Services
Table 96. Leading Biology HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Leading Biology Recent Developments/Updates
Table 98. BioVendor Laboratory Medicine Basic Information, Manufacturing Base and Competitors
Table 99. BioVendor Laboratory Medicine Major Business
Table 100. BioVendor Laboratory Medicine HP1 Antibody Product and Services
Table 101. BioVendor Laboratory Medicine HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. BioVendor Laboratory Medicine Recent Developments/Updates
Table 103. Active Motif Basic Information, Manufacturing Base and Competitors
Table 104. Active Motif Major Business
Table 105. Active Motif HP1 Antibody Product and Services
Table 106. Active Motif HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Active Motif Recent Developments/Updates
Table 108. Abeomics Basic Information, Manufacturing Base and Competitors
Table 109. Abeomics Major Business
Table 110. Abeomics HP1 Antibody Product and Services
Table 111. Abeomics HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. Abeomics Recent Developments/Updates
Table 113. Jingjie PTM BioLab Basic Information, Manufacturing Base and Competitors
Table 114. Jingjie PTM BioLab Major Business
Table 115. Jingjie PTM BioLab HP1 Antibody Product and Services
Table 116. Jingjie PTM BioLab HP1 Antibody Sales Quantity (L), Average Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 117. Jingjie PTM BioLab Recent Developments/Updates
Table 118. Global HP1 Antibody Sales Quantity by Manufacturer (2018-2023) & (L)
Table 119. Global HP1 Antibody Revenue by Manufacturer (2018-2023) & (USD Million)
Table 120. Global HP1 Antibody Average Price by Manufacturer (2018-2023) & (US$/L)
Table 121. Market Position of Manufacturers in HP1 Antibody, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 122. Head Office and HP1 Antibody Production Site of Key Manufacturer
Table 123. HP1 Antibody Market: Company Product Type Footprint
Table 124. HP1 Antibody Market: Company Product Application Footprint
Table 125. HP1 Antibody New Market Entrants and Barriers to Market Entry
Table 126. HP1 Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 127. Global HP1 Antibody Sales Quantity by Region (2018-2023) & (L)
Table 128. Global HP1 Antibody Sales Quantity by Region (2024-2029) & (L)
Table 129. Global HP1 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 130. Global HP1 Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 131. Global HP1 Antibody Average Price by Region (2018-2023) & (US$/L)
Table 132. Global HP1 Antibody Average Price by Region (2024-2029) & (US$/L)
Table 133. Global HP1 Antibody Sales Quantity by Type (2018-2023) & (L)
Table 134. Global HP1 Antibody Sales Quantity by Type (2024-2029) & (L)
Table 135. Global HP1 Antibody Consumption Value by Type (2018-2023) & (USD Million)
Table 136. Global HP1 Antibody Consumption Value by Type (2024-2029) & (USD Million)
Table 137. Global HP1 Antibody Average Price by Type (2018-2023) & (US$/L)
Table 138. Global HP1 Antibody Average Price by Type (2024-2029) & (US$/L)
Table 139. Global HP1 Antibody Sales Quantity by Application (2018-2023) & (L)
Table 140. Global HP1 Antibody Sales Quantity by Application (2024-2029) & (L)
Table 141. Global HP1 Antibody Consumption Value by Application (2018-2023) & (USD Million)
Table 142. Global HP1 Antibody Consumption Value by Application (2024-2029) & (USD Million)
Table 143. Global HP1 Antibody Average Price by Application (2018-2023) & (US$/L)
Table 144. Global HP1 Antibody Average Price by Application (2024-2029) & (US$/L)
Table 145. North America HP1 Antibody Sales Quantity by Type (2018-2023) & (L)
Table 146. North America HP1 Antibody Sales Quantity by Type (2024-2029) & (L)
Table 147. North America HP1 Antibody Sales Quantity by Application (2018-2023) & (L)
Table 148. North America HP1 Antibody Sales Quantity by Application (2024-2029) & (L)
Table 149. North America HP1 Antibody Sales Quantity by Country (2018-2023) & (L)
Table 150. North America HP1 Antibody Sales Quantity by Country (2024-2029) & (L)
Table 151. North America HP1 Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 152. North America HP1 Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 153. Europe HP1 Antibody Sales Quantity by Type (2018-2023) & (L)
Table 154. Europe HP1 Antibody Sales Quantity by Type (2024-2029) & (L)
Table 155. Europe HP1 Antibody Sales Quantity by Application (2018-2023) & (L)
Table 156. Europe HP1 Antibody Sales Quantity by Application (2024-2029) & (L)
Table 157. Europe HP1 Antibody Sales Quantity by Country (2018-2023) & (L)
Table 158. Europe HP1 Antibody Sales Quantity by Country (2024-2029) & (L)
Table 159. Europe HP1 Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 160. Europe HP1 Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 161. Asia-Pacific HP1 Antibody Sales Quantity by Type (2018-2023) & (L)
Table 162. Asia-Pacific HP1 Antibody Sales Quantity by Type (2024-2029) & (L)
Table 163. Asia-Pacific HP1 Antibody Sales Quantity by Application (2018-2023) & (L)
Table 164. Asia-Pacific HP1 Antibody Sales Quantity by Application (2024-2029) & (L)
Table 165. Asia-Pacific HP1 Antibody Sales Quantity by Region (2018-2023) & (L)
Table 166. Asia-Pacific HP1 Antibody Sales Quantity by Region (2024-2029) & (L)
Table 167. Asia-Pacific HP1 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 168. Asia-Pacific HP1 Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 169. South America HP1 Antibody Sales Quantity by Type (2018-2023) & (L)
Table 170. South America HP1 Antibody Sales Quantity by Type (2024-2029) & (L)
Table 171. South America HP1 Antibody Sales Quantity by Application (2018-2023) & (L)
Table 172. South America HP1 Antibody Sales Quantity by Application (2024-2029) & (L)
Table 173. South America HP1 Antibody Sales Quantity by Country (2018-2023) & (L)
Table 174. South America HP1 Antibody Sales Quantity by Country (2024-2029) & (L)
Table 175. South America HP1 Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 176. South America HP1 Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 177. Middle East & Africa HP1 Antibody Sales Quantity by Type (2018-2023) & (L)
Table 178. Middle East & Africa HP1 Antibody Sales Quantity by Type (2024-2029) & (L)
Table 179. Middle East & Africa HP1 Antibody Sales Quantity by Application (2018-2023) & (L)
Table 180. Middle East & Africa HP1 Antibody Sales Quantity by Application (2024-2029) & (L)
Table 181. Middle East & Africa HP1 Antibody Sales Quantity by Region (2018-2023) & (L)
Table 182. Middle East & Africa HP1 Antibody Sales Quantity by Region (2024-2029) & (L)
Table 183. Middle East & Africa HP1 Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 184. Middle East & Africa HP1 Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 185. HP1 Antibody Raw Material
Table 186. Key Manufacturers of HP1 Antibody Raw Materials
Table 187. HP1 Antibody Typical Distributors
Table 188. HP1 Antibody Typical Customers
List of Figures
Figure 1. HP1 Antibody Picture
Figure 2. Global HP1 Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global HP1 Antibody Consumption Value Market Share by Type in 2022
Figure 4. Monoclonal Examples
Figure 5. Polyclonal Examples
Figure 6. Global HP1 Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global HP1 Antibody Consumption Value Market Share by Application in 2022
Figure 8. Western Blot (WB) Examples
Figure 9. Immunochemistry (IHC) Examples
Figure 10. Immunofluorescence (IF) Examples
Figure 11. ELISA Examples
Figure 12. Others Examples
Figure 13. Global HP1 Antibody Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global HP1 Antibody Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global HP1 Antibody Sales Quantity (2018-2029) & (L)
Figure 16. Global HP1 Antibody Average Price (2018-2029) & (US$/L)
Figure 17. Global HP1 Antibody Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global HP1 Antibody Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of HP1 Antibody by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 HP1 Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 HP1 Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global HP1 Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global HP1 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 24. North America HP1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe HP1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific HP1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 27. South America HP1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa HP1 Antibody Consumption Value (2018-2029) & (USD Million)
Figure 29. Global HP1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global HP1 Antibody Consumption Value Market Share by Type (2018-2029)
Figure 31. Global HP1 Antibody Average Price by Type (2018-2029) & (US$/L)
Figure 32. Global HP1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global HP1 Antibody Consumption Value Market Share by Application (2018-2029)
Figure 34. Global HP1 Antibody Average Price by Application (2018-2029) & (US$/L)
Figure 35. North America HP1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America HP1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America HP1 Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America HP1 Antibody Consumption Value Market Share by Country (2018-2029)
Figure 39. United States HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe HP1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe HP1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe HP1 Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe HP1 Antibody Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific HP1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific HP1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific HP1 Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific HP1 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 55. China HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America HP1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America HP1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America HP1 Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America HP1 Antibody Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa HP1 Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa HP1 Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa HP1 Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa HP1 Antibody Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa HP1 Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. HP1 Antibody Market Drivers
Figure 76. HP1 Antibody Market Restraints
Figure 77. HP1 Antibody Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of HP1 Antibody in 2022
Figure 80. Manufacturing Process Analysis of HP1 Antibody
Figure 81. HP1 Antibody Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source